ArticleOncotarget2016

Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases.

Giuliana Cassinelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.